Emerald (EEX) Q1 2025 earnings summary

Executive summary

• Achieved double-digit revenue and adjusted EBITDA growth in Q1 2025, with revenue up 10.7% year-over-year to $147.7 million and adjusted EBITDA up 34.7% to $53.6 million, driven by organic growth, acquisitions, and portfolio optimization.

• Net income rose 39.1% to $15.3 million, reflecting higher operating income and improved margins despite increased non-recurring financing fees and tax provisions.

• Expanded share repurchase program to $25 million through December 2025, with $8.8 million repurchased in Q1.

• Regulatory approval received for the acquisition of This Is Beyond, expected to close in May, and completed InsurTech Insights acquisition.

• Declared a quarterly dividend of $0.015 per share for Q2 2025.

Financial highlights

• Q1 2025 revenue was $147.7 million, up 10.7% year-over-year; organic revenue grew 5.6% to $139.2 million.

• Adjusted EBITDA (excluding insurance proceeds) rose to $53.6 million, with a margin of 36.3%.

• Net income was $15.3 million, up from $11.0 million in Q1 2024; diluted EPS was $0.08.

• Free cash flow (excluding insurance proceeds) was $10.8 million, up from $3.8 million, with underlying FCF stronger if not for one-time refinancing fees and acquisition timing.

• Cash balance at March 31, 2025, was $276.8 million, with total liquidity of $386.8 million including a $110 million credit facility.

Outlook and guidance

• Full-year 2025 guidance reaffirmed: revenue of $450–$460 million and adjusted EBITDA of $120–$125 million.

• Guidance incorporates expected declines in international exhibitor revenue, especially from China and Canada, due to tariffs.

• Q2 and Q3 expected to be seasonally weaker, with Q4 anticipated to rebound and resemble Q1 in growth profile.

• Management remains vigilant regarding macroeconomic, trade-related, and regulatory risks, maintaining flexibility to adapt.

• Sufficient liquidity expected for the next twelve months and to fund long-term obligations.